Your browser doesn't support javascript.
loading
SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-ß1/Smad signaling.
Qi, Yan; Dong, Shuang-Shuang; He, Yong-Lai; Liu, Zi-Han; Huang, Ya-Lan; Wang, Ning; Zhang, Zhen; Li, Zhong; Shi, Mei Er Tu He Ta Mi; Feng, Xiao; Yao, Qing; Zou, Hong; Hu, Jian-Ming; Pang, Li-Juan; Li, Feng.
Afiliação
  • Qi Y; Department of Pathology, Central People's Hospital of Zhanjiang & Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, Guangdong, 524000, China. qiyanyan-1998@163.com.
  • Dong SS; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China. qiyanyan-1998@163.com.
  • He YL; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Liu ZH; Department of Pathology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, 225000, China.
  • Huang YL; Department of ICU, Central People's Hospital of Zhanjiang & Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, Guangdong, 524000, China.
  • Wang N; Department of Pathology, The Affiliated Hospital of Qingdao university, Qingdao, China.
  • Zhang Z; Department of Pathology, Suining Central Hospital, Suining, Sichuan, China.
  • Li Z; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Shi METHTM; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Feng X; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Yao Q; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Zou H; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Hu JM; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Pang LJ; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
  • Li F; Department of Pathology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, North 2 road, Shihezi, Xinjiang, 832002, China.
BMC Cancer ; 22(1): 166, 2022 Feb 12.
Article em En | MEDLINE | ID: mdl-35151264
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Transdução de Sinais / Proteínas de Fusão Oncogênica / Sarcoma Sinovial Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Transdução de Sinais / Proteínas de Fusão Oncogênica / Sarcoma Sinovial Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article